Search Follow us


NeuroVive Pharmaceutical

EdisonTV | Pharmaceutical & healthcare | 24/04/2018

Bitesize briefing - NeuroVive Pharmaceutical

Mitochondrial disease is an umbrella term that includes a diverse set of conditions where the function of the mitochondria is failing. The diversity of the clinical presentation, low incidence rates and high unmet need make this an interesting area for specialist orphan drug developers. Here, healthcare analyst Dr Jonas Peciulis presents an overview of mitochondrial medicine, the competitive landscape in drug development and discusses one of the companies covered by Edison, specialising in the field, NeuroVive Pharmaceutical.

Read the report

» NeuroVive Pharmaceutical overview & latest research